Kazia Therapeutics Limited (KZIA:NASDAQ) soared at $6.4, a gain of 50.6%. On Thu 06 Aug 20, KZIA:NASDAQ hit a New 2-Week Intraday High of $4.5. The stock appeared on our News Catalysts scanner on Fri 07 Aug 20 at 11:13 AM in the 'BIOTECH' category. From Thu 23 Jul 20, the stock recorded 40.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Conduent Incorporated (CNDT:NASDAQ), 82.74%
- Addex Therapeutics Ltd (ADXN:NASDAQ), 70.45%
- Groupon, Inc. (GRPN:NASDAQ), 56.66%
- OpGen, Inc. (OPGN:NASDAQ), 52.49%
- Huttig Building Products, Inc. (HBP:NASDAQ), 52.12%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 50.59%
- Sirius International Insurance Group, Ltd. (SG:NASDAQ), 45.42%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 44.83%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 38.43%
- ShotSpotter, Inc. (SSTI:NASDAQ), 28.29%